LIP
MDT icon

Liontrust Investment Partners’s Medtronic MDT Stock Holding History

Liontrust Investment Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45,753
Closed -$10.1M – 221
2021
Q3 		$10.1M Buy
+45,753
New +$5.92M 0.14% 83
2020
Q4 		$756K Buy
+6,450
New +$710K 0.02% 185

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Liontrust Investment Partners's MDT Position: Q4 2021 in Review

Liontrust Investment Partners sold out of Medtronic (MDT) in Q4 2021, closing a stake of 45,753 shares — an estimated $10.1M sold.

Liontrust Investment Partners first reported a position in MDT in Q4 2020 and held it in 2 quarters. The position peaked at $10.1M in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Liontrust Investment Partners reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Liontrust Investment Partners sold 45,753 Medtronic shares in Q4 2021, an estimated $10.1M.
  • Liontrust Investment Partners first reported a position in Medtronic in Q4 2020 and held it in 2 quarters.
  • Liontrust Investment Partners's Medtronic position peaked at $10.1M in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Liontrust Investment Partners's 13F filing for Q4 2021, filed 26 Jan 2022.